49
Growth Score in past quarter
pts
Heat Score 49 in past quarter
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
421004
Excelse Bio is focused on improved formulation and delivery of injectable biotechnology products to change therapy as we know it today.
- Michael Reilly: CEO & Co-founderPast Role: OnCirc Diagnostics, CEO
About the Company
Excelse Bio, headquartered in Thousand Oaks, California, is focused on improved formulation and delivery of injectable biotechnology products to change therapy as we know it today. lab It was founded by biologics experts in protein formulation from Amgen and other leading biotechnology firms. Their team of leading scientists have deep experience in
high concentration formulation and are able to apply the EXCELSEâ„¢ technology to a variety of delicate biotechnology drugs.
Excelse Bio is a privately held company, an affiliate of Integrity Bio, Inc., a leader in biotechnology formulation services established in 2003. Excelse Bio has ongoing research studies with large biotechnology and biopharmaceutical partners.